BKS Advisors’s Pfizer PFE Stock Holding History

BKS Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$348K	Sell	8,640 -846	-9%	-$33.9K	0.14%	140
2018 Q4	$393K	Buy	9,486 +2,061	+28%	+$85.6K	0.18%	126
2018 Q3	$310K	Hold	7,425	–	–	0.11%	160
2018 Q2	$256K	Sell	7,425 -570	-7%	-$19.5K	0.09%	179
2018 Q1	$269K	Sell	7,995 -184	-2%	-$6.33K	0.1%	171
2017 Q4	$281K	Sell	8,179 -572	-7%	-$19.5K	0.1%	165
2017 Q3	$296K	Buy	8,751 +201	+2%	+$6.46K	0.11%	154
2017 Q2	$272K	Sell	8,550 -211	-2%	-$6.65K	0.11%	160
2017 Q1	$284K	Buy	8,761 +79	+0.9%	+$2.49K	0.12%	151
2016 Q4	$268K	Buy	8,682 +448	+5%	+$13.7K	0.13%	149
2016 Q3	$265K	Buy	8,234 +1	+0%	+$33	0.12%	142
2016 Q2	$275K	Sell	8,233 -316	-4%	-$10.1K	0.14%	137
2016 Q1	$240K	Buy	+8,549	New	+$244K	0.13%	148

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BKS Advisors's PFE Position: Q1 2019 in Review

BKS Advisors reduced its Pfizer (PFE) stake by 8.9% in Q1 2019, selling an estimated $33.9K and leaving 8,640 shares worth $348K. The position accounts for 0.14% of the portfolio, ranked #140.

BKS Advisors first reported a position in PFE in Q1 2016 and has held it in 13 quarters since. The position peaked at $393K in Q4 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

BKS Advisors held 8,640 shares of Pfizer worth $348K as of Q1 2019.
BKS Advisors sold 846 Pfizer shares in Q1 2019, an estimated $33.9K.
Pfizer made up 0.14% of BKS Advisors's portfolio in Q1 2019, its #140 holding.
BKS Advisors first reported a position in Pfizer in Q1 2016 and has held it in 13 quarters since.
BKS Advisors's Pfizer position peaked at $393K in Q4 2018.
2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.